Description
Voglibose 0.3mg + Metformin 500 mg (S.R) Tablets – VOGLIBOSE + METFORMIN is classified as anti-diabetic medication. It is utilized for managing type 2 diabetes mellitus. Diabetes is a condition of metabolism that results in elevated levels of glucose in the bloodstream. It happens when insulin, a hormone made by the pancreas’ beta cells, is unable to effectively process glucose for energy (insulin resistance) or when the pancreas produces minimal or no insulin.
Voglibose and Metformin Hydrochloride Prolonged Release Tablets consist of Voglibose and Metformin, two medications used for diabetes. Voglibose belongs to the group of medications known as alpha-glucosidase inhibitors. It operates by hindering the digestive enzymes in the intestines, breaking down complex sugars into simple sugars (like glucose). Therefore, insulin aids in taking the glucose out of the bloodstream. Metformin PR slowly releases smaller amounts of the medication throughout an extended period. It hinders the liver cells’ production of sugar and decreases its absorption from the intestine.
How Does Voglibose & Metformin Hydrochloride Prolonged Tablet Work?
This medication functions by regulating blood sugar levels. Voglibose is classified as an alpha-glucosidase inhibitor. By hindering the intestinal enzymes that convert complex sugars into glucose, it hampers the absorption of glucose. This procedure stops blood sugar levels from spiking right after eating. Metformin is a type of biguanide that decreases glucose production in the liver, lowers glucose absorption from the intestines, and enhances insulin sensitivity in the body.
Uses of Voglibose& Metformin Hydrochloride Prolonged Tablets
Voglibose and Metformin Hydrochloride Prolonged Release Tablets are frequently recommended for the treatment of type 2 diabetes. Listed below are the main purposes for which they are used.
- Voglibose is a type of alpha-glucosidase inhibitor that reduces the levels of glucose in the body after meals, promoting efficient glucose utilization. This medicine is mainly recommended in combination with a healthy diet and physical activity to manage blood glucose levels in individuals with type 2 diabetes.
- Metformin is an antibiotic drug that mitigates the amount of sugar production made by the liver and improves the body’s response to insulin. It also helps lower blood sugar by increasing glucose in muscle cells. Metformin is commonly the initial treatment recommended for type 2 diabetes, often prescribed alongside lifestyle modifications like diet and physical activity.
The combination of Voglibose and metformin hydrochloride in an extended-release tablet helps to effectively manage blood sugar levels all day, leading to more consistent glucose levels and possibly lowering the chance of experiencing hypoglycemia compared to other diabetes drugs. When taking these medications, it is important to follow your doctor’s instructions carefully and check your blood sugar levels regularly.
Side Effects
- Stomach pain
- Nausea
- Diarrhea
- Vomiting
- Headache
- Bloating
- Loss of appetite
Precautions
- Voglibose& Metformin tablet is not recommended for children.
- Avoid breastfeeding while taking Voglibose& Metformin as it may pass through the human milk.
- Avoid alcohol consumption
- Patients with heart and liver conditions should exercise caution when using this medication.
- Inform your doctor if you have a history of heart disease, liver issues, or kidney problems.
Frequently Asked Questions (FAQs)
Q1. What are voglibose 0.3 mg and metformin 500mg used for?
Together, they help to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals.
Q2. What food cannot be taken while taking Voglibose & metformin?
Eating foods that can spike your blood sugar will increase the burden on the body.
Q3. What not to drink with Voglibose & metformin?
Avoid alcoholism, as this may put you at risk for lactic acidosis. This condition occurs when there is an excessive amount of lactic acid present in the bloodstream, leading to potential severe illness.
